MC
Michael Cherny Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Premier
PINC
$2.13B
| $25.85 | $21 |
19%
downside
| Underperform | 19 days ago |
|
|
2
Premier
PINC
$2.13B
| $25.85 | $26 |
1%
upside
| Market Perform | 19 days ago |
|
3
Cardinal Health
CAH
$35.7B
| $149.56 | $186 |
24%
upside
| Outperform | 25 days ago |
|
4
Progyny
PGNY
$1.94B
| $22.55 | $28 |
24%
upside
| Outperform | 2 months ago |
|
|
5
Cardinal Health
CAH
$35.7B
| $149.56 | $170 |
14%
upside
| Buy | 2 months ago |
|
6
McKesson
MCK
$85.5B
| $687.40 | $800 |
16%
upside
| Buy | 4 months ago |
|
7
Envista
NVST
$3.54B
| $21.31 | $23 |
8%
upside
| Buy | 4 months ago |
|
8
Medpace
MEDP
$13.7B
| $486.98 | $330 |
32%
downside
| Market Perform | 5 months ago |
|
9
Hims & Hers Health
HIMS
$10.9B
| $48.41 | $40 |
17%
downside
| Market Perform | 6 months ago |
|
10
CVS Health
CVS
$93.6B
| $73.78 | $75 |
2%
upside
| Outperform | 6 months ago |
|
|
11
Progyny
PGNY
$1.94B
| $22.55 | $25 |
11%
upside
| Buy | 6 months ago |
|
12
Doximity
DOCS
$13B
| $69.34 | $90 |
30%
upside
| Outperform | 7 months ago |
|
13
Align Technology
ALGN
$10.1B
| $139.12 | $280 |
101%
upside
| Outperform | 8 months ago |
|
14
Quest Diagnostics
DGX
$20.5B
| $183.49 | $174 |
5%
downside
| Outperform | 8 months ago |
|
15
Henry Schein
HSIC
$8.42B
| $69.43 | $84 |
21%
upside
| Buy | 8 months ago |
|
16
IQVIA
IQV
$31.9B
| $187.68 | $248 |
32%
upside
| Outperform | 9 months ago |
|
17
Icon
ICLR
$13.6B
| $174.88 | $255 |
46%
upside
| Outperform | 9 months ago |
|
|
18
Envista
NVST
$3.54B
| $21.31 | $23 |
8%
upside
| Market Perform | 10 months ago |
|
|
19
Hims & Hers Health
HIMS
$10.9B
| $48.41 | $25 |
48%
downside
| Buy | 10 months ago |
|
|
20
McKesson
MCK
$85.5B
| $687.40 | $630 |
8%
downside
| Outperform | 11 months ago |
|
21
Cencora
COR
$56.7B
| $292.50 | $275 |
6%
downside
| Outperform | 11 months ago |
|
|
22
CVS Health
CVS
$93.6B
| $73.78 | $77 |
4%
upside
| Buy | 1 year ago |
|
23
Labcorp
LH
$23.2B
| $278.67 | $260 |
7%
downside
| Outperform | 1 year ago |
|
24
GoodRx Holdings
GDRX
$1.39B
| $4 | $8 |
100%
upside
| Outperform | 1 year ago |
|
25
Certara
CERT
$1.69B
| $10.52 | $19 |
81%
upside
| Market Perform | 1 year ago |
|